CD44 and cancer: We found that CD44, an established cancer stem cell marker known to promote EMT54,55, was most highly expressed in the hEMT state across TCGA cancers (Fig. 5e), and elevated levels of several other stemness signatures most often accompanied the hEMT and MES macro-states (Figure S7c, d).